Correlation Between Corvus Pharmaceuticals and Gamida Cell

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Gamida Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Gamida Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Gamida Cell, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Gamida Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Gamida Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Gamida Cell.

Diversification Opportunities for Corvus Pharmaceuticals and Gamida Cell

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Corvus and Gamida is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Gamida Cell in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gamida Cell and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Gamida Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gamida Cell has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Gamida Cell go up and down completely randomly.

Pair Corralation between Corvus Pharmaceuticals and Gamida Cell

If you would invest (100.00) in Gamida Cell on November 29, 2024 and sell it today you would earn a total of  100.00  from holding Gamida Cell or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Corvus Pharmaceuticals  vs.  Gamida Cell

 Performance 
       Timeline  
Corvus Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Corvus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Gamida Cell 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Gamida Cell has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental indicators, Gamida Cell is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Corvus Pharmaceuticals and Gamida Cell Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Corvus Pharmaceuticals and Gamida Cell

The main advantage of trading using opposite Corvus Pharmaceuticals and Gamida Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Gamida Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gamida Cell will offset losses from the drop in Gamida Cell's long position.
The idea behind Corvus Pharmaceuticals and Gamida Cell pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance